Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4556 Gene Editing

Trading 07-31 15:23:12 EDT

407.55

-8.05

-1.94%

High420.03	Low402.23	Vol4.05M
Open415.84	D1 Closing415.59	Amplitude4.28%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O72.81M	T/O Rate--	Tradable Shares0.00
P/B2.549628	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":407.5454,"timestamp":1785525792142,"preClose":415.59042,"halted":0,"volume":4054347,"delay":0,"changeRate":-0.019358,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-8.045013,"latestTime":"07-31 15:23:12 EDT","open":415.83914,"high":420.0319,"low":402.22623,"amount":72806495.663506,"amplitude":0.042844,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785528000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.549628,"peRate":-8.074879,"turnoverRate":0.008766,"increases":0,"decrements":4,"flats":0,"marketCap":9177418432,"floatMarketCap":8777978944},"requestUrl":"/m/hq/s/BK4556/tweets","defaultTab":"tweets","newsList":[{"id":"2655872831","title":"Intellia Therapeutics Schedules Conference Call to Discuss Q2 2026 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872831?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:01","pubTimestamp":1785412907,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics schedules conference call to discuss Q2 2026 results and business updatesIntellia scheduled a conference call for Aug. 6, 2026 at 8 a.m. ET to discuss Q2 2026 results, business u","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLBHJMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","BK4585","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","LU1861559042.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","BK4139","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","BK4556","IE00BKPKM429.USD","BK4588","IE00BN0W2T93.GBP","BCDF","BK4535","NTLA","LU2210150020.SGD","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654730049","title":"Opening Day: Scribe Therapeutics makes strong trading debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2654730049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654730049?lang=en_us&edition=fundamental","pubTime":"2026-07-27 23:25","pubTimestamp":1785165946,"startTime":"0","endTime":"0","summary":"Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opening-day-scribe-therapeutics-makes-strong-trading-debut-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opening-day-scribe-therapeutics-makes-strong-trading-debut-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4611","CRSP","LU1861559042.SGD","NVIB","SYNB","BK4588","BK4585","ARKG","LU1861558580.USD","XBIX","SCTX","IPOS","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054786","title":"CRISPR Therapeutics (CRSP) Enters Phase 1 With CTX112 In Allogeneic CAR T","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054786","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054786?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:20","pubTimestamp":1784989202,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (NasdaqGM:CRSP) has moved its allogeneic CAR T candidate CTX112 into Phase 1 clinical trials.\nThe program targets lymphoma and certain autoimmune diseases with an off the shelf cell therapy approach.\nThe company is positioning CTX112 within the broader CAR T market, which currently relies heavily on individualized patient specific treatments.\n\nFor investors following CRISPR Therapeutics, CTX112 marks a meaningful extension of the company’s focus beyond its earlier gene...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-enters-phase-1-with-ctx112-in-allog","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-enters-phase-1-with-ctx112-in-allog","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CAR","BK4585","CRSP","BK4611","LU1861558580.USD","SYNB","BK4230","BK4556","BK4022","LU1861559042.SGD","BK4588","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744593","title":"Beam Therapeutics Announces Press Release Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744593","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653744593?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:05","pubTimestamp":1784804717,"startTime":"0","endTime":"0","summary":"Beam Therapeutics announces press release availabilityBeam Therapeutics announced it will present updated Phase 1/2 data for BEAM-302 in alpha-1 antitrypsin deficiency at ERS Congress 2026.Late-breaki","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDLqRkTF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4585","BEAM","BK4611","LU2210150020.SGD","LU1861558580.USD","IE00BKPKM429.USD","BK4556","IE00BN0W2T93.GBP","LU1861559042.SGD","IE00BGHQF748.EUR","BK4588","SG9999014013.SGD","BK4505","SG9999014005.SGD","LU2095319765.USD","BCDF","BK4535","NDAQ","IE00BN0W2V16.EUR","BK4139","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014039.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653479215","title":"Beam Therapeutics (BEAM) Following Ark Invest Interest And Clinical Milestones Looks Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2653479215","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653479215?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:27","pubTimestamp":1784762843,"startTime":"0","endTime":"0","summary":"Beam Therapeutics (BEAM) is back in focus after Ark Invest increased its position, as investors weigh upcoming clinical milestones, including a global BEAM-302 trial and a planned FDA marketing application for risto-cel.\nSee our latest analysis for Beam Therapeutics.\nDespite Ark Invest’s increased stake and Beam Therapeutics’ upcoming clinical milestones, recent momentum has been weak, with the share price down 25.0% over 30 days and the 1-year total shareholder return still positive at...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-beam/beam-therapeutics/news/beam-therapeutics-beam-following-ark-invest-interest-and-cli","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-beam/beam-therapeutics/news/beam-therapeutics-beam-following-ark-invest-interest-and-cli","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4505","LU1861558580.USD","BK4588","BK4611","BEAM","BK4585","BK4139","LU1861559042.SGD","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425736","title":"Crispr Therapeutics Expands Autoimmune Pipeline With New CTX112 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425736?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219506,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics ($CRSP) announced an update on their ongoing clinical study. Crispr Therapeutics (CRSP) is running an early stage trial to test...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crispr-therapeutics-expands-autoimmune-pipeline-with-new-ctx112-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crispr-therapeutics-expands-autoimmune-pipeline-with-new-ctx112-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","ARKG","BK4585","BK4588","BK4611","BK4539","BK4139","BK4007","CRSP","LU1861558580.USD","BK4556","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4556","nameEN":"BK4556"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Gene Editing,BK4556,Gene Editing股票,Gene Editing股票老虎,Gene Editing股票老虎国际,Gene Editing行情,Gene Editing股票行情,Gene Editing股价,Gene Editing股市,Gene Editing股票价格,Gene Editing股票交易,Gene Editing股票购买,Gene Editing股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction